Mennini, F. S., Paoletti, M., Bini, C., Marcellusi, A., Falcone, M. and Andreoni, M. (2022) “Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP)”, Global and Regional Health Technology Assessment, 9(1), pp. 45–57. doi: 10.33393/grhta.2022.2287.